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Endovascular repair of abdominal aortic aneurysm
without preoperative arteriography
Mark C. Wyers, MD, Mark F. Fillinger, MD, Marc L. Schermerhorn, MD, Richard J. Powell, MD,
Eva M. Rzucidlo, MD, Daniel B. Walsh, MD, Robert M. Zwolak, MD, PhD, and
Jack L. Cronenwett, MD, Lebanon, NH
Objective: Clinical trials of endovascular aortic aneurysm repair (EVAR) have required both preoperative aortography and
computed tomography (CT). We codeveloped specialized three-dimensional (3-D) reconstruction and computer-aided
measurement, planning, and simulation software (3-D CAMPS) based on CT or magnetic resonance imaging, to
eliminate the need for preoperative arteriography.
Methods: EVAR with 3-D CAMPS as the sole preoperative imaging method was performed in 196 patients from 1996 to
2001, with six endograft types in three configurations. Physical examination, abdominal radiography, and CT (3D-
CAMPS) were performed at 1, 6, and 12 months, then annually.
Results: For a subset of cases in which a comparison could be made, 3-D CAMPS was superior to angiography for
prediction of endograft length and iliac access. Hospital mortality was zero, and 30-day mortality was 0.5%. In three
patients immediate conversion to open repair (1.5%) was necessary because of previously unknown stent-graft mechanical
limits. Incidence of endoleak was 15% at 1 month, 10% at 6 months, 6% at 12 months, and 7% at 24 months, and 92% of
endoleaks were type II. Mean follow-up was 18 months. Aneurysm-related mortality was zero. Nineteen secondary
procedures (all endovascular) were performed in 16 patients (8%). For all graft types, freedom from secondary procedure
was 94% at 1 year and 90% at 2 years, and this was better for endografts ultimately approved by the US Food and Drug
Administration (96% at 1 year, 95% at 2 years; P  .02). No known measurement-related complications occurred in the
series. Results for secondary intervention and endoleak compare favorably to series with similar endograft types.
Conclusions: EVAR can be performed with 3-D CAMPS as the sole preoperative imaging method to achieve outcomes
comparable to the best series published for each endograft type. CT with 3-D CAMPS can effectively eliminate the need
for preoperative arteriography and avert associated morbidity, expense, and exposure to contrast agent and radiation. (J
Vasc Surg 2003;38:730-8.)
Preoperative imaging has been a crucial part of endo-
vascular aneurysm repair (EVAR) since the earliest reports
of clinical success by Parodi et al.1 Unlike open aortic
aneurysm repair, EVAR depends on knowing the patient’s
anatomy well enough to select and size a graft preopera-
tively. Even a 2-mm error in stent-graft size can lead to
attachment site endoleak, migration, or other complica-
tions, all of which may result in open conversion or second-
ary intervention, and even aneurysm rupture. Over time,
endovascular treatment of abdominal aortic aneurysm
(AAA) has increased in scope and complexity. New graft
designs and deployment systems have broadened the spec-
trum of EVAR to encompass a large variety of endograft
sizes, configurations (tube, bifurcated, aortoiliac), and fix-
ation options (suprarenal vs infrarenal). More recent de-
vices can be used in arteries with more severe tortuosity and
in more diseased access vessels. In many centers, 40% to
80% of infrarenal aortic aneurysms currently are treated
with EVAR, with a variety of devices.2-4 Each device has
relative strengths and limitations for addressing specific
anatomic constraints, and must be selected accordingly. In
addition, preoperative planning may be needed for intraop-
erative adjuncts such as coil embolization, angioplasty,
renal and iliac stenting, femoral endarterectomy, and iliac
conduits. Thus accurate preoperative imaging is extremely
important to ensure proper selection of patients, stent-graft
type, and potential intraoperative adjuncts.
Because of the complexity of preoperative planning, it
is ironic that a less invasive method of aneurysm repair is
associated with more invasive preoperative evaluation. In
initial reports of EVAR and in every major clinical trial of
endografts, both computed tomography (CT) and arte-
riography were required, for aneurysm diameter and length
measurements, respectively.5-9 Arteriography with a grad-
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uated marked catheter was required because of the limita-
tions of conventional CT, namely, inability to measure
length along the vessel axis and poor evaluation of occlusive
disease. To eliminate the need for preoperative arteriogra-
phy, we helped to develop three-dimensional computer-
aided modeling, planning, and simulation software (3-D
CAMPS) for evaluation of vascular anatomy.10-12 This
system should not be confused with conventional CT, CT
“angiography” (CTA), or CTA with conventional 3-D
reconstruction.10-12 The purpose of this study was to eval-
uate the utility of 3-D CAMPS for preoperative evaluation
of patients who might be candidates for EVAR.
METHODS
We reviewed our database of 202 consecutive primary
endovascular AAA repairs performed at Dartmouth-
Hitchcock Medical Center (Lebanon, NH) and the White
River Junction Veterans Administration Medical Center
(White River Junction, VT) from June 1996 to December
2001. This period encompassed all patients entered in
“learning curve” clinical trials, including the interval when
only aortoaortic tube grafts were available. Two hundred
two patients had data available for analysis. However, early
in our experience, arteriography was used in six patients to
aid in graft sizing or assessment of occlusive disease, and
data for these patients were excluded from the analysis.
CT imaging protocol. The primary preoperative im-
aging method used in all patients was spiral CT in conjunc-
tion with 3-D reconstruction and 3-D CAMPS software
(Preview; Medical Media Systems, West Lebanon, NH).
CT protocols for single-array scanners are designed to
cover the area of interest, that is, celiac artery to common
femoral arteries, with good detail of branch vessels and
adequate resolution for high-quality 3D reconstruc-
tions.10-12 Primary features included contrast medium in-
jection at 3 to 4 mL/s (timed via CT monitoring or timing
of a test bolus), with total volume typically 120 mL of
iodinated contrast agent; collimation (beam thickness) 3
mm in the visceral aortic segment and 5 to 7 mm in the
distal abdomen-pelvis region; and pitch of 1 (ratio of table
speed to collimation). The primary alternate protocol in-
cluded collimation of 5 mm, with pitch of 1.5 to 2, to
image the necessary length from celiac artery to femoral
arteries. With newer multiple-array scanners the protocol is
similar, with an effective collimation of 2.5 mm and pitch of
2. Reformatting in the axial, sagittal, and coronal planes
was in 2-mm increments, and reformatting perpendicular
to the vessel was in 1-mm increments. Patients with severe
renal insufficiency but not receiving dialysis underwent
magnetic resonance angiography (MRA) to delineate the
anatomy with 3-D reconstruction (five patients), but also
underwent unenhanced CT because MRA does not detect
or display calcified plaque well.12,13 Alternate strategies
included gadolinium-enhanced CT or, more recently, ace-
tylcysteine prophylaxis and nonionic contrast agent in pa-
tients with moderate renal insufficiency (creatinine concen-
tration, 2-3).10-12,14
Electronic data from CTA or MRA was sent in Dicom
format for postprocessing (Medical Media Systems), in-
cluding multiplanar reformatting encompassing the entire
volume of the scan in sagittal, coronal, and axial planes at 2
mm intervals. The cross-sectional image data are used to
“segment” or delineate the boundaries of contrast-
enhanced lumen, calcified plaque, and thrombus or non-
calcified atheroma, which have the same density, as separate
objects in a multi-object surface-shaded display 3-D model.
The model retains all 3-D information, so the integrity of
measurements in 3-D space can be maintained along with
interactive display of measurements and CT data. The
centerline of the vessel is recreated in 3-D space and refor-
matted in planes orthogonal (perpendicular) to this center-
line along the entire 3-D model, in 1-mm increments. All of
this information is loaded onto a CD-ROM disk along with
software that enables display and measurement on a per-
sonal computer for 3-D CAMPS.
3-D CAMPS. 3-D CAMPS consists of several key
components,10-12 all of which were used:
1. Source images from a high-quality axial imaging source
that includes imaging of the vessel lumen (ie, CTA or
MRA)
2. Multiplanar reformatted CTA or MRA data at small
intervals in multiple planes
3. 3-D multi-object surface-shaded display of the vascular
anatomy, with individual display of contrast-enhanced
lumen, calcified plaque, and thrombus or atheroma
4. CT or MR reformatted data in planes orthogonal to
the vessel in 3-D space
5. Length measurements along the centerline of the ves-
sel lumen
6. Length measurements along a user-defined 3-D path
7. 3-D simulation of the endograft within the aortoiliac
anatomy (“virtual graft”)
8. Interactive confirmation that the 3-D model is an
accurate representation of the CT or MR data (“drop
sections” where the CT reformat is displayed within
the 3-D model)
9. Interactive measurements displayed simultaneously
within the CT data and the 3-D model in real time
10. Ability to simulate the appropriate C-arm gantry angle
for optimal views of the aortic and iliac attachment
sites, including the renal and internal iliac artery
origins10-12
Preoperative planning. 3-D CAMPS software and
images on personal computers were used by the implanting
surgeon to obtain measurements of aneurysm neck diame-
ter and length, neck-AAA body angle, iliac diameter, and
iliac attachment site length. In all cases, CT reformatting
perpendicular to the vessel was used for diameter, with
real-time display in the 3-D reconstruction of all length,
angle, and diameter measurements.10-12 Length measure-
ments for seal and fixation length and length over the graft
path were calculated with 3-D CAMPS.11 Iliac artery tor-
tuosity and calcification were also analyzed to plan access
and delivery of the intended device. Sagittal reformatting
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and the 3-D model were used to plan the optimal C-arm
gantry angle for deployment at the proximal neck.11,15 The
proposed graft was then simulated in the patient’s 3-D
anatomy, anticipating that the stent graft will generally
follow the lumen centerline, but allowing simulations that
follow a user-defined path11 as well (Fig 1). Determination
of a potential endograft path that did not follow the cen-
terline was left to surgeon judgment, and the total length of
Fig 1. Composite of preoperative and postoperative three-dimensional reconstruction and computer-aided measure-
ment, planning, and simulation (3D-CAMPS) images and intraoperative angiograms from the same patient.
A, 3-Dimensional image of infrarenal abdominal aortic aneurysm with flow channel (red), calcified plaque (white)
atheroma and thrombus (yellow). B, Same view as in A, with thrombus made invisible to simulate intraoperative
arteriogram. C, Intraoperative arteriogram. D, Preoperative virtual graft simulation with “reversed limb” configuration
to show intentional crossing of graft limbs within the aneurysm sac. E, Intraoperative completion arteriogram.
F, One-month follow-up 3D-CAMPS study.
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such a user-defined endograft path almost never differed by
more than 1 cm (in total length) from the centerline
endograft path. Endograft size was based on 3-D CAMPS,
including a simulation of the proposed endograft within
the AAA, accounting for the side of delivery (differences in
ipsilateral and contralateral length), planned extensions,
and delivery device size (differing for main device and
contralateral limb). Planning also included determination
of renal artery location on the basis of lumbar spine land-
marks (for placement of the marker catheter if a pre-
deployment “road map” was used). Last, the optimal C-
arm gantry angle for viewing the infrarenal aortic neck
attachment site and the internal iliac artery origins were
determined.
Intraoperative technique. All EVARs were per-
formed in the operating room, with a 12-inch digital C-arm
fluoroscopy unit (Philips BV 312, Philips Medical Systems,
Santa Ana, Calif; or GE/OEC 9800, GE Medical Systems,
Milwaukee, Wis). 3D-CAMPS reconstructions were avail-
able on a personal computer in the operating room for
reference as needed. For patients with renal insufficiency,
contrast agent was limited by placing guide wires, sheaths,
and the deployment device in the appropriate location,
with the 3-D reconstruction as the road map. The gantry
angles were adjusted according to the preoperative CAMPS
plan. After early misjudgments based on arteriogram inter-
pretations, we learned to refer to 3-D CAMPS if the arte-
riogram did not appear to correlate with the preoperative
plan. Arteriograms were most commonly misinterpreted in
two scenarios: before we routinely planned appropriate
gantry angles for the aorta, common iliac, and internal iliac
arteries, before the procedure; and when we relied on the
marker catheter for length and the catheter took an unex-
pectedly much shorter path than the planned endograft.
Completion arteriography was always performed, with an-
tegrade contrast injection at the proximal attachment site
and separate retrograde injection in both iliac arteries.
Other injection sites were used, as deemed necessary, if
endoleak was present (junction injection, separate views),
to rule out type I or type III endoleak. Most grafts were
placed with the patient under general anesthesia (74%), and
the rest were placed with the patient under regional
anesthesia.
Patient follow-up. Patients participating in phase II
or phase III clinical trials and patients with commercially
available grafts were seen at follow-up at 1, 6, and 12
months, with annual visits thereafter. Interim visits were
scheduled as clinically indicated or per manufacturer rec-
ommendations for trial patients. Each visit included a pa-
tient interview, review of systems, physical examination,
determination of ankle-brachial index, CT with 3D recon-
struction including computer-aided volume measure-
ments, and plain abdominal radiography (four views).
Statistical evaluation. Data were collected via retro-
spective review of electronic and paper medical records and
organized into a File Maker Pro version 5.0 database (File-
maker Inc, Santa Clara, Calif) configured by us. Statistical
evaluation including Kaplan-Meier analysis, with the log-
rank or Mantel-Cox method for comparison of groups, was
performed with StatView version 5.0 statistical software
(SAS Institute, Cary, NC). Results are given as mean SD
unless otherwise specified. P  .05 was considered statisti-
cally significant.
RESULTS
Initial verification of accuracy. Although validation
was performed in objects of known size and in open AAA
repairs before initiation of this series, validation during
EVAR was performed also. Intraoperative intravascular ul-
trasound (IVUS) was used in the first 25 patients to confirm
preoperative 3-D CAMPS arterial diameter measurements.
IVUS and 3-D CAMPS diameter measurements agreed
sufficiently (mean difference, 0.5  0.3 mm; P  .2) that
the chosen graft diameter was not affected in any case. No
changes in operative plan were made on the basis of these
results. Similarly, intraoperative arteriography with a grad-
uated marked catheter was used to confirm length measure-
ments in the first 35 cases. The preoperative simulation of
the endograft length (with virtual graft) was within 5 mm of
the actual graft end point in all but one endograft limb, and
within 10 mm in all endograft limbs (measured relative to
the internal iliac artery or aortic bifurcation on completion
graduated marked catheter arteriography in an appropriate
plane). Graft length measurements with 3-D CAMPS and
arteriograms were similar (141 6 mm vs 136 6 mm; P
 .08), but in 19% the measurements differed by 1 cm or
more (shorter on arteriograms in all cases). Completion
and postoperative studies of the actual graft demonstrated
that 3-D CAMPS was more accurate in all discordant cases.
Arteriography was not accurate for diameter measurements
(mean error for aortic neck measurements compared with
IVUS, 2.6  2 mm, with arteriography underestimating
diameter in 80% of cases).
Early in our experience (first 82 cases), 3-D CAMPS
was prospectively used to identify patients with difficult but
feasible access (n  14). In extreme cases when 3-D
CAMPS predicted probable access failure (n  4), preop-
erative arteriography was performed to make the final de-
termination of whether transfemoral access should be at-
tempted. Arteriography was falsely reassuring in three of
these four cases, resulting in the only three access failures in
our experience. Arteriography is no longer used for deter-
mination of access issues, and no preoperative arteriogram
has been obtained since December 1998. 3D-CAMPS
alone was used to evaluate the access vessels in the 196
patients in this series without any access failure.
Patient demographic data. Mean patient age at pri-
mary endovascular graft implantation was 74  7 years.
Mean follow-up time was 18  1 months. Most patients
were men (83%) with significant associated comorbid con-
ditions (Table I, online only). Six stent-graft brands were
implanted (n  196): AneuRx (Medtronic/AVE, Santa
Rosa, Calif), n 107; EVT (now Ancure; Guidant, Menlo
Park, Calif), n  14; Excluder (W. L. Gore & Assoc,
Flagstaff, Ariz), n  42; Lifepath (Baxter/Edwards Life
Sciences, Irvine, Calif), n  2; Vanguard I (Boston Scien-
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tific, Meadox Medicals, Oakland, NJ), n  30; and Talent
(Medtronic/AVE), n  1. The endograft types included
the graft configurations available at the time, that is, tube,
bifurcated, and aortouniiliac (Table II). Anatomic data
(standard definitions) were as follows: maximum AAA di-
ameter, 58  9 mm; aortic neck diameter, 23  2 mm;
aortic neck length, 28 11 mm; and 3-D neck-body angle,
32  16 degrees.16 As compared with arteriography, no
patent accessory renal arteries or inferior mesenteric arteries
were missed at preoperative 3-D CAMPS (note in Fig 1,
A-F, lowest left accessory renal artery preoperatively fills via
collateral vessels postoperatively after intentional
coverage).
Technical success. Successful graft implantation was
achieved in 98.5% of patients, with the three exceptions
(1.5%) all early in our experience. In these three patients
immediate conversion to open repair was successful. Con-
version was necessary because of previously unknown me-
chanical limitations of the devices in two patients (tortuos-
ity limitations for one EVT graft and one Vanguard graft)
and inadvertent dislodgement of the iliac graft limb in one
patient. Angulation or tortuosity limits for these devices
were subsequently measured preoperatively (before device
redesign or discontinuation), and no other immediate con-
version or access failure occurred in the subsequent 158
endografts implantations since March 1998.
Adjunctive techniques. Adjunctive techniques were
used in 53 patients (27%) to assist graft implantation,
including iliac stent (n  6), iliofemoral conduit (n  5),
femorofemoral bypass for aortouniiliac grafts (n  8),
brachial artery access (n  2), common femoral artery
repair with patch angioplasty (n  16), and intentional
hypogastric artery occlusion to treat combined aortoiliac
aneurysm (n  32; previously reported17). In all but 6
patients the need for adjunctive techniques was predicted
preoperatively on the basis of 3D-CAMPS images. The
most common adjunctive procedure that was not planned
preoperatively was iliac stenting (4 of 6), usually performed
to stent a nonsupported endograft limb at the site of
stenosis that did not respond to angioplasty after deploy-
ment (n  2) or to treat external iliac dissection or kink
secondary to the stent graft or its deployment (n 1 each).
One retroperitoneal approach to the common iliac artery
with iliofemoral conduit was performed emergently to treat
iliac artery injury caused by balloon rupture during angio-
plasty of stenosis before EVG deployment, with subsequent
successful EVG deployment.
Early results. In-hospital mortality was zero. Thirty-
day mortality was 0.5%; one patient was doing well until he
had a stroke at home 2 weeks after discharge. This patient
had a history of multiple strokes due to intracranial cere-
brovascular occlusive disease. Mean length of stay for pa-
tients receiving EVAR was 2  3 days (SD), with 56% of
patients discharged on postoperative day 1 (median length
of stay, 1 day). Eight patients required intensive care unit
stay, for a combined total of 17 patient-days in the intensive
care unit. All other patients were transferred to the inpa-
tient floor after a 4-hour observation period in the post-
anesthesia care unit. In-hospital complications are shown in
Table III. There were no apparent measurement-related
complications.
Late results. Life table survival rate was 91% at 1 year
and 78% at 3 years. Aneurysm-related mortality after 30
days was zero. Life table method did not show any signifi-
cant difference in survival according to graft type (differ-
ence not significant).
Endoleak. Incidence of endoleak was 15% at 1 month,
10% at 6 months, 6% at 12 months, and 7% at 24 months;
and 92% of endoleaks were type II (Fig 2, online only). All
primary endoleaks were type II, most associated with lum-
bar branch flow only. A minority of type II endoleaks
involved branch flow from the inferior mesenteric artery or
an accessory renal artery arising from the AAA sac (n  1).
The number of endoleaks decreased over time, primarily
because of spontaneous resolution (86%). All type I and
type III endoleaks were secondary endoleaks in three cate-
gories: aneurysm degeneration within attachment sites or
adjacent arterial segments (n 2, distal type I), stent-graft
Table II. Graft types and configurations
Graft
Configuration
Type
No. of
grafts
AneuRx (n  107) Bifurcated 97
Tube 3
Aortouniiliac 7
EVT (n  14) (now Ancure) Bifurcated 5
Tube 6
Aortouniiliac 3
Excluder (n  42) Bifurcated 42
Lifepath (n  2) Tube 2
Talent (n  1) Tube 1
Vanguard (n  30) Bifurcated 26
Tube 4
Table III. Perioperative complications
Complication
Incidence
n %
Myocardial infarction* 3 1.5
Arrhythmia 6 3
Transient renal
deterioration
†
12 6
Hemodialysis 1 0.5
Respiratory failure
‡
3 1.5
Urinary retention 7 3.5
Peripheral neurologic injury
§
2 1
ABI reduction
¶
7 3.5
ABI, Ankle-brachial index.
*Troponin change without ECG change for 2 of 3.
†
Greater than 30% rise in serum creatinine concentration.
‡
Intubation  2 d.
§
Lower extremity plexopathy or radiculopathy.
¶
Reduction in postoperative ABI  0.14; includes endovascular graft limb
occlusions.
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deformation (n 3, “buckling” associated with sac shrink-
age), or small fabric wear or suture hole endoleak (n  1).
Secondary procedures. Eighteen secondary proce-
dures, all endovascular, were performed in 16 patients
(8%). All type I and type III endoleaks were corrected with
secondary interventions. Type II endoleaks were generally
observed if the aneurysm was not enlarging. Early in the
series, three type II endoleaks were coiled, without evi-
dence of AAA enlargement, before evidence that not all
type II endoleaks need intervention. Limb occlusion oc-
curred in 5 grafts (2 EVT, 2 Vanguard, 1 AneuRx). There
were two late ruptures, both in Vanguard I endografts with
stent-graft degradation (small suture hole or fabric wear, n
 1; buckling of the trunk and migration of the “docking”
limb attachment, n  1; both 2 years postimplantation);
both were successfully repaired with another endograft.
Vanguard I endografts were involved in 15% of EVAR but
58% of secondary procedures (P  .01), although longer
follow-up may account for part of this difference. For the
entire series, overall freedom from secondary procedure
was 94% at 1 year and 90% at 2 years. The results are
significantly better for graft types that were ultimately
approved by the US Food and Drug Administration, that is,
AneuRx, Excluder, and EVT (freedom from intervention at
1 and 2 years, 96% and 95%, respectively), compared with
graft types that did not achieve FDA approval and were
subsequently redesigned or abandoned, primarily Van-
guard I (freedom from intervention at 1 and 2 years, 90%
and 82%, respectively; P  .02; Fig 3). No endoleaks or
secondary procedures appeared to be caused by measure-
ment errors; all demonstrated clear stent-graft degradation,
stent deformation, or aneurysm deterioration of the native
artery.
DISCUSSION
This study demonstrates that 3-D CAMPS can be used
effectively for patient selection and stent-graft sizing for
endovascular AAA repair. For each type of stent graft,
clinical results with CAMPS are equivalent to or better than
those of published series from large academic institutions of
excellence in which preoperative arteriography was used in
most or all cases (Table IV).18-23 In addition, our second-
ary intervention rate compares favorably with that of Euro-
star,23 the largest multiple device study available (Fig 4).
Our anatomic data are nearly identical to those of Eurostar,
and mean AAA diameter, a predictor of adverse outcome, is
larger for our series. Of course, our good results could be
due to extremely conservative patient selection or large
institutional experience, but that is not likely the case.
Several patients in this series were turned down for endo-
vascular repair at other large institutions, yet underwent
successful endovascular repair with use of preoperative
CAMPS for stent-graft sizing and procedural planning.
Traditional measures of “degree of difficulty” for EVAR,
such as aneurysm size, are typical for large published series.
Most important, this report includes patients treated dur-
Fig 3. Freedom from secondary intervention over time. There was a notable difference between grafts that were
ultimately approved by the US Food and Drug Administration (FDA) and those that were not approved. Freedom from
secondary intervention at 12 and 24 months was 96% and 95%, respectively, for endografts ultimately approved by the
FDA, significantly better than for non–FDA-approved endografts.
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ing our early experience “learning curve,” dating back to
1996, when endovascular AAA repair was being performed
in only a small number of US centers. This series does not
exclude early experience with each endograft in each new
clinical trial, early experience for multiple surgeons, and
early experience performing endovascular AAA repair with-
out preoperative arteriography. All of these factors would
generally mitigate against good results.24,25
Although it is difficult to confirm the superiority of a
technique without a prospective, randomized study, there
are some areas where 3-D CAMPS has clear advantage over
arteriography: it is less invasive, less expensive, and averts
use of iodinated contrast agent and radiation required for
arteriography. At our institution the cost (not charge) for
3-D CAMPS is currently less than half that for diagnostic
arteriography alone ($550 vs $1109). Aortofemoral arte-
riography is not a “high-risk” procedure, but is associated
with complications that may require intervention in 1.7% of
patients undergoing transfemoral diagnostic arteriography
(eg, bleeding, pseudoaneurysm, dissection) and can even
Table IV. Comparison with reported series that used preoperative angiography
Mixed graft type series Single graft type series
EUROSTAR Bush* Datillo
DHMC
(entire
series)
Makaroun
(Ancure)
Zarins
(AneuRx)
Matsumura
(Excluder)
DHMC
(FDA-
approved)
Mean follow-up (mo) 27 18 18 17.5 24 18 (14-17) 15
Technical success (%) 98.4 94 98.6 98.5 90-96 98 100 99.4
Freedom from secondary
intervention (2 y) (%)
75 75 NR 90 NR 90 86 95
Endoleak rate at 2 y (%) 24 25* NR 7 20 13
†
20 6
Late rupture rate (%) 1 0 0.8 1 0 0 0 0
Survival (%) 87 86 NR 88 94 76 87 88
AAA-related mortality (%) NR 2 1.3 0 NR 0.3 0 0
DHMC, Dartmouth Hitchcock Medical Center; AAA, abdominal aortic; NR, not reported.
*“Low-risk” portion of Bush et al series.
†
Rate at 1 y.
Fig 4. Freedom from secondary intervention compared with EUROSTAR registry (January 2001), comprised of a
similar mix of graft types approved and not approved by the US Food and Drug Administration over a similar period
of time.
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cause fatal complications (0.025%).26-28 In addition, the
two advantages traditionally ascribed to arteriography,
therapeutic intervention and evaluation of occlusive dis-
ease, are affected by the context of EVAR. A pre-existing
stent along the path of the delivery system creates the
potential for stent deformation and vessel damage while
trying to pass the large delivery systems associated with
EVAR. Most interventionalists prefer to dilate the lesion
with an introducer sheath, then stent the lesion with the
endograft or an uncovered stent at completion if necessary.
Renal stents are similarly better placed after the endograft is
deployed, because the typical renal stent must encroach
into the aortic lumen, where it may interfere with device
deployment or become damaged during EVAR.
In the small number of early cases where we used
arteriography for decision-making, we quickly found that it
was not the gold standard for issues such as determining
diameter, device length, and iliac access, despite making
these decisions in conjunction with proctors who had ex-
perience with more than 100 cases in which preoperative
arteriography was used. The tendency of arteriography to
underestimate true diameter has been reported previous-
ly.29 Determination of neck length is inferior because arte-
riography visualizes only the lumen and not thrombus. We
also found that 3-D CAMPS ability to simulate the appro-
priate c-arm gantry angle for optimal views of the aortic and
iliac attachment sites, including the renal and internal iliac
artery origins, was important for obtaining appropriate
attachment sites, limiting trial-and-error contrast injec-
tions, and limiting use of cuffs. We used only two aortic
cuffs in this entire series, which is far fewer than most series
that report this statistic. In our experience, preoperative
arteriography has also been inferior for evaluating iliac
occlusive disease and determining suitability of access for
the delivery device. Even with two or more views, signifi-
cant stenoses can be missed at arteriography because it gives
a two-dimensional projection of a three-dimensional struc-
ture. Bilateral pressure gradients or “spin pelvis” systems
can minimize this problem, but few centers routinely per-
form bilateral iliac pressure gradients, and the equipment
for 3-D spin arteriography is expensive. Vessel calcification
is often demonstrated poorly on arteriograms as well, and
calcified plaque, even if not hemodynamically significant,
may impede access or deployment.
On the other hand, while trying to minimize preoper-
ative testing and expense, one might question whether CT
alone, without 3-D CAMPS or arteriography, might be just
as effective. We have no doubt that EVAR can be per-
formed with CT alone, but it is unlikely that it can be
performed without more conservative patient selection or
without some additional risks compared with 3-D CAMPS.
It must be emphasized that the 3-D CAMPS system we
used in this study is not conventional CT, CTA, or even
conventional CTA with 3-D reconstruction (see Meth-
ods).10-12 The protocols for all major clinical EVAR trials
initially required CT and arteriography with a marker cath-
eter, because with conventional CT it is difficult to assess
occlusive disease, measure the length of potential attach-
ment sites, or determine appropriate stent-graft
length.29-31 CTA improves assessment of occlusive dis-
ease,30,31 but has not been as effective as 3-D CAMPS in
our hands, as evidenced by access issues in our validation
series in which we used a combination of CT and angiog-
raphy. Axial CT has the problem of slightly overcalling the
true diameter,32 which is averted with 3-D CAMPS by CT
reformatting orthogonal to the vessel.11,32 Conventional
3-D reconstructions are based only on brightly contrasted
structures (ie, contrast-enhanced lumen and calcified
plaque), because of the problem with automated edge
detection of thrombus and noncalcified atheroma. Thus
they have the dual problems of overcalling the potential
lumen for the device, because the calcified plaque is dis-
played identically with true lumen, and undercalling the
true extent of the aneurysm, because the thrombus is not
included in the 3-D reconstruction. Moreover, most 3-D
reconstruction software lacks ability to measure length
along the lumen centerline or along a user-specified path,
display the CT reformatting interactively with the 3-D
model to confirm its accuracy, or display measurements in
the context of the model. We have found all of these
elements invaluable during evaluation of AAA for potential
EVAR.
There are some caveats about 3-D CAMPS as well.
Proper CT protocols are important, but these are a simple
matter compared with more technician-dependent or
software-dependent imaging, such as duplex scanning or
MRA. CAMPS can be used with MR as well as CT, but one
must remember the inherent limitations of MR: lack of
differentiation for calcified plaque and lower resolution
(generally half that of CT, but improved with the latest
generation of scanners). There is significant training time
for technicians if the 3-D CAMPS technique is to be
performed in the hospital, but this time and expense can be
resolved by using a third-party solution, as in this study.
Most centers will likely wish to use a third-party solution,
because this type of software is now reimbursed by the
Center for Medicare and Medicaid Services and does not
require the high initial training cost or high initial costs
associated with in-house solutions. Training is also required
for the surgeon or interventionalist who will use 3-D
CAMPS for patient selection and planning, but the learning
curve for this is relatively low for computer-literate persons.
For those who are not computer-savvy, however, this tech-
nique will be more difficult to learn. The overall time for
preoperative evaluation and planning is significant, but
should ultimately be less tedious and time-consuming than
using a combination of CT and arteriography, especially
when results of these studies are contradictory. Last, there
is no substitute for good judgment, that is, not “pushing
the envelope” with marginal anatomy if there is a good
option for open repair.
This study is not large enough to rigorously evaluate
outcomes with the various endografts used. However, as
one might expect, the best results were obtained with
devices that have ultimately been approved for commercial
use (Ancure, AneuRx, Excluder), and most of the second-
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ary interventions were required after implantation of an
early generation device that was ultimately discontinued
(Vanguard I). No secondary interventions were necessary
because of measurement errors, but because of device
deformation, progression of aneurysm disease, or type II
endoleak, none of which were related to preoperative plan-
ning.
In conclusion, this study demonstrates that 3-D
CAMPS can be used effectively for patient selection and
stent-graft sizing for EVAR, and provides results that are as
good as or better than those of series in which preoperative
arteriography was used. Compared with CT plus arteriog-
raphy, CT or MR with 3-D CAMPS is less invasive, less
expensive, and associated with lower contrast agent and
radiation dose. We have made 3-D CAMPS the standard
patient evaluation technique at our institution, and we
believe elimination of preoperative arteriography will be-
come more widespread as other centers gain experience
with this technique.
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